GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human retinoid X receptor alpha-ligand binding domain complex with 9-cis retinoic acid and the coactivator peptide grip-1

Analyse Crystal structure of human retinoid X receptor alpha-ligand binding domain… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3OAP
Type
protein
Length
225 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor rxr-alpha; Nuclear receptor coactivator 2
UniProt
P19793, Q15596
Ligands
9CR
Pockets
2 · best druggability 0.85

Structure

x-ray diffraction · 2 distinct chains · 71% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor rxr-alphaprotein21471% helix, 3% strandP19793
BNuclear receptor coactivator 2protein1173% helix, 0% strandQ15596

Ligands and binding sites

  • 9CR · (9cis)-retinoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12580.850.96379CR
21690.420.7320empty

Interfaces

1 interface between chains.

  • A–B · 577 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 3OAP · Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.